208 related articles for article (PubMed ID: 1966580)
21. Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine.
Isaka M; Komiya T; Takahashi M; Yasuda Y; Taniguchi T; Zhao Y; Matano K; Matsui H; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
Vaccine; 2004 Aug; 22(23-24):3061-8. PubMed ID: 15297056
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant effect of cholera toxin on the mucosal immune response to soluble proteins. Differences between mouse strains and protein antigens.
Wilson AD; Stokes CR; Bourne FJ
Scand J Immunol; 1989 Jun; 29(6):739-45. PubMed ID: 2740843
[TBL] [Abstract][Full Text] [Related]
23. Immunogenic properties of plant-derived recombinant smallpox vaccine candidate pB5.
Portocarrero C; Markley K; Koprowski H; Spitsin S; Golovkin M
Vaccine; 2008 Oct; 26(43):5535-40. PubMed ID: 18706953
[TBL] [Abstract][Full Text] [Related]
24. Manipulation of intestinal immune responses against ovalbumin by cholera toxin and its B subunit in mice.
Van der Heijden PJ; Bianchi AT; Dol M; Pals JW; Stok W; Bokhout BA
Immunology; 1991 Jan; 72(1):89-93. PubMed ID: 1705237
[TBL] [Abstract][Full Text] [Related]
25. Cholera toxin as a mucosal adjuvant. Glutaraldehyde treatment dissociates adjuvanticity from toxicity.
Liang XP; Lamm ME; Nedrud JG
J Immunol; 1989 Jul; 143(2):484-90. PubMed ID: 2544646
[TBL] [Abstract][Full Text] [Related]
26. Neonatal sublingual vaccination with Salmonella proteins and adjuvant cholera toxin or CpG oligodeoxynucleotides induces mucosal and systemic immunity in mice.
Huang CF; Wang CC; Wu TC; Wu KG; Lee CC; Peng HJ
J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):262-71. PubMed ID: 18376242
[TBL] [Abstract][Full Text] [Related]
27. Oral and intraperitoneal immunization with rotavirus 2/6 virus-like particles stimulates a systemic and mucosal immune response in mice.
Shuttleworth G; Eckery DC; Awram P
Arch Virol; 2005 Feb; 150(2):341-9. PubMed ID: 15578236
[TBL] [Abstract][Full Text] [Related]
28. Mucosal memory B cells retain the ability to produce IgM antibodies 2 years after oral immunization.
Vajdy M; Lycke N
Immunology; 1995 Nov; 86(3):336-42. PubMed ID: 8550068
[TBL] [Abstract][Full Text] [Related]
29. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.
Hotomi M; Ikeda Y; Suzumoto M; Yamauchi K; Green BA; Zlotnick G; Billal DS; Shimada J; Fujihara K; Yamanaka N
Vaccine; 2005 Jan; 23(10):1294-300. PubMed ID: 15652672
[TBL] [Abstract][Full Text] [Related]
30. Immune responses of mice to orally administered asialo GM1-specific rabbit IgG in the presence or absence of cholera toxin.
Umesaki Y; Setoyama H
Immunology; 1992 Feb; 75(2):386-8. PubMed ID: 1551702
[TBL] [Abstract][Full Text] [Related]
31. Importance of gastrointestinal ingestion and macromolecular antigens in the vein for oral tolerance induction.
Wakabayashi A; Kumagai Y; Watari E; Shimizu M; Utsuyama M; Hirokawa K; Takahashi H
Immunology; 2006 Oct; 119(2):167-77. PubMed ID: 16796692
[TBL] [Abstract][Full Text] [Related]
32. Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses.
Kato H; Fujihashi K; Kato R; Yuki Y; McGhee JR
J Immunol; 2001 Mar; 166(5):3114-21. PubMed ID: 11207263
[TBL] [Abstract][Full Text] [Related]
33. Low-dose oral tolerance due to antigen in the diet suppresses differentially the cholera toxin-adjuvantized IgE, IgA and IgG response.
Christensen HR; Kjaer TM; Frøkiaer H
Int Arch Allergy Immunol; 2003 Nov; 132(3):248-57. PubMed ID: 14646386
[TBL] [Abstract][Full Text] [Related]
34. Ingestion of yogurt containing Lactobacillus acidophilus and Bifidobacterium to potentiate immunoglobulin A responses to cholera toxin in mice.
Tejada-Simon MV; Lee JH; Ustunol Z; Pestka JJ
J Dairy Sci; 1999 Apr; 82(4):649-60. PubMed ID: 10212452
[TBL] [Abstract][Full Text] [Related]
35. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen.
Elson CO; Ealding W
J Immunol; 1984 Dec; 133(6):2892-7. PubMed ID: 6491278
[TBL] [Abstract][Full Text] [Related]
36. Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis.
Blanchard TG; Lycke N; Czinn SJ; Nedrud JG
Immunology; 1998 May; 94(1):22-7. PubMed ID: 9708182
[TBL] [Abstract][Full Text] [Related]
37. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.
Jackson RJ; Fujihashi K; Xu-Amano J; Kiyono H; Elson CO; McGhee JR
Infect Immun; 1993 Oct; 61(10):4272-9. PubMed ID: 8406816
[TBL] [Abstract][Full Text] [Related]
38. Correlations between antibody immune responses at different mucosal effector sites are controlled by antigen type and dosage.
Externest D; Meckelein B; Schmidt MA; Frey A
Infect Immun; 2000 Jul; 68(7):3830-9. PubMed ID: 10858191
[TBL] [Abstract][Full Text] [Related]
39. Mucosal immunogenicity and adjuvanticity of cholera toxin in swine.
Foss DL; Murtaugh MP
Vaccine; 1999 Feb; 17(7-8):788-801. PubMed ID: 10067684
[TBL] [Abstract][Full Text] [Related]
40. Oral immunogenicity of the plant proteinase bromelain.
Hale LP; Fitzhugh DJ; Staats HF
Int Immunopharmacol; 2006 Dec; 6(13-14):2038-46. PubMed ID: 17161360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
